Masahiro Hirakawa

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy et al. · New England Journal of Medicine · 2016 · 594 citations · Full text

Medicine, Immunology, Oncology +15

Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells

Masahiro Hirakawa, Tiago R. Matos, Hongye Liu et al. · JCI Insight · 2016 · 138 citations · Full text

Life Sciences, Hematology, Immunology +15

Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study

Yasushi Sato, Hiroyuki Ohnuma, Takayuki Nobuoka et al. · Gastric Cancer · 2016 · 97 citations · Full text

Medicine, Oncology, Chemotherapy +9

Fucosylated TGF-β receptors transduces a signal for epithelial–mesenchymal transition in colorectal cancer cells

Masahiro Hirakawa, Rishu Takimoto, Fumito Tamura et al. · British Journal of Cancer · 2013 · 95 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach

Makoto Yoshida, Rishu Takimoto, Kazuyuki Murase et al. · PLoS ONE · 2012 · 64 citations · Full text

Pharmacy, Oncology, Pharmacology +17